Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000250584 | SCV000320044 | benign | Cardiovascular phenotype | 2022-10-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000865942 | SCV000512026 | likely benign | not provided | 2020-09-11 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23631430) |
Invitae | RCV001433540 | SCV001636331 | likely benign | Long QT syndrome | 2020-11-11 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003955405 | SCV004779806 | likely benign | ANK2-related condition | 2022-09-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |